Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jun:85:101070.
doi: 10.1016/j.resmer.2023.101070. Epub 2023 Nov 30.

Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases

Marine Fargeas  1 , Gilles Devouassoux  2 , Mathieu Gerfaud-Valentin  3
Affiliations
Case Reports

Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases

Marine Fargeas et al. Respir Med Res. 2024 Jun.
No abstract available

Keywords: Benralizumab; Dupilumab; EGPA; Eosinophilic granulomatosis with polyangiitis; Mepolizumab; Severe asthma.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest GD declare to be consultant for ALK, Astra-Zeneca, Boehringer Ingelheim, Chiesi, GSK, Menarini, Mundi Pharma, Novartis Pharma, Roche, Sanofi, Vivisol, to participate to medical meeting for AGIR adom, ALK, Astra-Zeneca, Boehringer Ingelheim, Chiesi, CIPLA, GSK, Meda, MSD, Novartis Pharma, Orkyn, SANOFI, Takeda, TEVA, to be investigators of clinical assays for AB Science, ALK, Amgen, Astra Zeneca, Boehringer-Ingelheim, Genentech, Gossamer, GSK, Lilly, Novartis Pharma, Regeneron, Roche, SANOFI, TEVA, Vitalair, Zambon to bet research fundings from Agir adom, ALLP, Chiesi, GSK, MSD, Novartis Pharma, Orkyn, Takeda, Vivisol. MGV declare to be consultant for Sobi, Novartis and Amgen.

MeSH terms

Substances